A protein called NF-kB c-Rel has been found to intensify the symptoms of psoriasis, offering a potential new target for ...

"Psoriasis can be a challenging condition to manage due to long-term treatments with various side effects. SFA-002's effect in the imiquimod-induced mouse model is compelling. The results ...

Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria.

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

A potential new psoriasis treatment restores the function of certain anti-inflammatory immune cells in a targeted manner.

With the key role of SSAT in the inflammatory process, the researchers have simultaneously discovered a new starting point for therapy: In a mouse model with psoriasis-like skin inflammation ...